| Carole Wilson, NP | |
|
1130 N Baldwin Ave, Marion, IN 46952-2536 | |
| (765) 660-7480 | |
| (765) 382-4495 |
| Full Name | Carole Wilson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 21 Years |
| Location | 1130 N Baldwin Ave, Marion, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093820896 | NPI | - | NPPES |
| 200487860 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 71001615 (Indiana) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 71001615A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marion General Hospital | Marion, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Marion General Hospital | 9133023625 | 98 |
News Archive
Researchers at Umeå University have developed a model that uses seasonal weather data from satellite images to accurately predict outbreak of malaria with a one-month lead time.
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
For millions of American children and teens playing sports, good nutrition is critical for maximum health, performance and normal growth.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.
› Verified 3 days ago
| Entity Name | Marion General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528099041 PECOS PAC ID: 9133023625 Enrollment ID: O20040524001483 |
News Archive
Researchers at Umeå University have developed a model that uses seasonal weather data from satellite images to accurately predict outbreak of malaria with a one-month lead time.
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
For millions of American children and teens playing sports, good nutrition is critical for maximum health, performance and normal growth.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.
› Verified 3 days ago
| Entity Name | Inphynet Primary Care Physicians Midwest, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528090610 PECOS PAC ID: 6507808946 Enrollment ID: O20050525001352 |
News Archive
Researchers at Umeå University have developed a model that uses seasonal weather data from satellite images to accurately predict outbreak of malaria with a one-month lead time.
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
For millions of American children and teens playing sports, good nutrition is critical for maximum health, performance and normal growth.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carole Wilson, NP 330 N Wabash, Ste G20, Marion, IN 46952-2600 Ph: (765) 660-7616 | Carole Wilson, NP 1130 N Baldwin Ave, Marion, IN 46952-2536 Ph: (765) 660-7480 |
News Archive
Researchers at Umeå University have developed a model that uses seasonal weather data from satellite images to accurately predict outbreak of malaria with a one-month lead time.
Osteologix, Inc. through its wholly owned Irish subsidiary Osteologix Limited and the Servier Research Group, the leading French independent pharmaceutical company, today announced that Osteologix has granted Servier an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental indications worldwide, except in the U.S. NB S101 is an innovative molecule acting on both bone formation and bone resorption.
For millions of American children and teens playing sports, good nutrition is critical for maximum health, performance and normal growth.
"Civil society groups [in the U.S.] are praising parts of President Barack Obama's newly unveiled [FY 2014 budget request], saying it appears to build on momentum gathered in recent years toward a robust overhaul of the U.S. Agency for International Development, the country's main foreign aid agency," Inter Press Service reports.
Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today it has commenced a tender offer through its wholly owned subsidiary, Spark Acquisition Corporation, for all of the outstanding shares of common stock (the "Shares") of Celera Corporation (Nasdaq: CRA), one of the world's pioneers in genetic diagnostics discovery and development for $8.00 per share in cash, without interest and less any required withholding taxes.
› Verified 3 days ago
Mrs. Thomasina Marie Wrangham, RN, MSN, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 6484 E 100 S, Marion, IN 46953 Phone: 765-667-3411 | |
Mrs. Nina Elaine Orr, AGPCNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1700 E 38th St, Marion, IN 46953 Phone: 765-674-3321 | |
Heather D Brady, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 119 S Washington St, Marion, IN 46952 Phone: 765-660-7440 Fax: 765-662-4712 | |
Elizabeth Huffman, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 925 S Nebraska St, Marion, IN 46953 Phone: 765-664-7492 | |
Peggy Ann Dulhanty, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1700 E 38th St, Marion, IN 46953 Phone: 765-674-3321 Fax: 765-677-5162 | |
Mrs. Jennifer R Hite, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 706 N River Dr, Marion, IN 46952 Phone: 800-622-6575 | |
Pamela Sue Billiter-yoder, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1614 N Baldwin Ave, Marion, IN 46952 Phone: 765-665-9000 Fax: 765-664-9009 |